Brief: Shareholders Oppose Plan Of Arrangement Between Emerald Health Therapeutics And Skye Biosciences Inc
04/08/2022 11:06
Aug 4 (Reuters) - Emerald Health Therapeutics Inc EMH.CD :
* GROUP OF SHAREHOLDERS OPPOSE PLAN OF ARRANGEMENT BETWEEN
EMERALD
HEALTH THERAPEUTICS AND SKYE BIOSCIENCES INC.
* OPPOSING SHAREHOLDERS OF EMERALD HEALTH THERAPEUTICS SAY
THEY
OPPOSE ANNOUNCED PLAN OF ARRANGEMENT BETWEEN EMERALD AND SKYE
BIOSCIENCES INC
Source text for Eikon: ID:nCNWkHyfPa
Further company coverage: EMH.CD
Recent news on Skye Bioscience
See all newsBrief: Skye Announces Cohort Review Committee Approved Opening Of Cohort 2 Based On Favorable Safety Data From First Four Participants Treated In Cohort 1
U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis
U.S. STOCKS ON THE MOVE-Tesla, Blue Owl, Ford
U.S. STOCKS ON THE MOVE-Energy firms, Estee Lauder, HMH Holding
Skye Bioscience rises as it begins testing higher doses of obesity drug